Chinese competition hurting Indian drugmakersBy
You might think that India’s pharmaceutical industry would be one business where locals needn’t fret too much about competition from China. While China has no big-name drugmakers with significant presence beyond the People’s Republic, India’s pharma industry is one of the country’s great success stories. Companies like Ranbaxy, Dr Reddy’s and Cipla are recognized worldwide for their high-quality, low-cost products. The Indians have helped revolutionize the world’s generics industry and some companies are trying, albeit with mixed results, to become players in the risky world of new drug discovery.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.